Navigation Links
Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
Date:8/20/2007

Opening Bell Ceremony Marks Kendle's 10th Anniversary as Public Company

CINCINNATI, Aug. 20 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Chairman and CEO Candace Kendle, PharmD, will ring the opening bell at the NASDAQ Stock Market on Aug. 22, 2007, the company's 10th anniversary as a publicly-traded company. The Opening Bell ceremony will take place at 9:30 a.m. Eastern Time at the NASDAQ MarketSite(R) in New York's Times Square and will be broadcast live on http://www.nasdaq.com and on the seven-story NASDAQ tower, the largest stationary video screen in the world.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

NASDAQ Opening Bell Ceremony - Webcam Instructions

To view the NASDAQ Opening Bell ceremony, go to http://www.kendle.com or http://www.nasdaq.com/about/marketsitetowervideo.asx. Please note:

-- Viewers must have Windows Media Player to view the webcam (Windows

Media Player is downloadable at no charge from

http://www.microsoft.com/windows/windowsmedia/default.aspx).

-- It is recommended viewers download the webcam at 9:15 a.m. so there is

time to troubleshoot in the event of technical difficulties

-- Prior to 9:20 a.m., the webcam will show the Tower; at 9:20 a.m. the

router will be switched and viewers will see inside the MarketSite

studio where the ceremony will take place

-- Viewers should not be alarmed that the webcam is fuzzy. Clarity is

dependent on Internet hook up.

NASDAQ Opening Bell Ceremony - Satellite Feed Information

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. For questions, please contact Jolene Libretto at NASDAQ at (646) 441-5220.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle

Copyright©2007 PR Newswire.

Related biology technology :

1. Merge files financial reports by market opening
2. NASDAQ will continue to list Merge
3. NASDAQ grants Merge more time for compliance
4. NASDAQ will continue to list Merge
5. No word on NASDAQ extension for Merge
6. NASDAQ puts Merge on notice again
7. Midwest life science stocks kept sizzling in Q2
8. Madisons PunchStock acquired by Getty Images
9. Midwest life science stocks sizzle in a tepid first quarter
10. Sonic Foundry completes $11.25M stock offer
11. Sonic Foundry sets $3.75 stock price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2016)... ... May 18, 2016 , ... Every day, more than ... asthma complications.* Costing more than $56 billion in direct costs annually, asthma remains ... too many, the suffering associated with uncontrolled asthma can be overwhelmingly disproportionate and ...
(Date:5/17/2016)... ... 2016 , ... DryLet, LLC, a biotechnology company providing an ... be showcasing ManureMagic™ at booth V1061 at the World Pork Expo, June 8-10 ... last year and more recently made news as the results were released from ...
(Date:5/17/2016)... , May 17, 2016 ... in Basel, Switzerland announced ... inhibitor of P38 mitogen-activated protein kinase. ... Strekin will build the necessary research foundation ... in which MAP Kinases play fundamental roles. Pamapimod ...
(Date:5/17/2016)... ... May 17, 2016 , ... New tests that go ... country promising more specific information that both the patient and doctor want and need ... tests, presented at the American Urological Association’s annual meeting in San Diego, involve using ...
Breaking Biology Technology:
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):